Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Spondyloarthritis

Closing the gap in psoriatic arthritis

A group of experts in rheumatology and dermatology has identified many unmet needs in the care of patients with psoriatic arthritis and offered potential solutions. But do their recommendations go far enough?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Helliwell, P. et al. Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22404.

  2. Kane, D. & Pathare, S. Early psoriatic arthritis. Rheum. Dis. Clin. North Am. 31, 641–657 (2005).

    Article  PubMed  Google Scholar 

  3. Kavanaugh, A. F., Ritchlin, C. T. & GRAPPA Treatment Guideline Committee. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J. Rheumatol. 33, 1417–1421 (2006).

    PubMed  Google Scholar 

  4. Englbrecht, M. et al. Measuring joint involvement in polyarticular psoriatic arthritis: an introduction of alternatives. Arthritis Care Res. 62, 977–983 (2010).

    Article  CAS  Google Scholar 

  5. Coates, L. C. et al. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis Rheum. 65, 1504–1509 (2013).

    Article  PubMed  Google Scholar 

  6. Fagerli, K. M. et al. Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study. Ann. Rheum. Dis. 72, 1840–1844 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Wu, N., Lee, Y. C., Shah, N. & Harrison, D. J. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study. Clin. Ther. 36, 1231–1241.e3 (2014).

    Article  PubMed  Google Scholar 

  8. Dandorfer, S. W., Rech, J., Manger, B., Schett, G. & Englbrecht, M. Differences in the patient's and the physician's perspective of disease in psoriatic arthritis. Semin. Arthritis Rheum. 42, 32–41 (2012).

    Article  PubMed  Google Scholar 

  9. Husted, J. A. et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res. (Hoboken) 63, 1729–1735 (2011).

    Article  Google Scholar 

  10. Di Minno, M. N. et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann. Rheum. Dis. 73, 1157–1162 (2014).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher Ritchlin.

Ethics declarations

Competing interests

The author declares that he has acted as a consultant for Amgen, Abbvie, Janssen and UCB, and received funding for research from Amgen and UCB.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ritchlin, C. Closing the gap in psoriatic arthritis. Nat Rev Rheumatol 10, 704–705 (2014). https://doi.org/10.1038/nrrheum.2014.169

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2014.169

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing